Molecular Templates Inc (MTEM)

Molecular Templates (MTEM) Stock Price & Analysis


MTEM Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.31 - $1.23
Previous Close$0.48
Average Volume (3M)778.35K
Market Cap
Enterprise Value$34.10M
Total Cash (Recent Filing)$41.67M
Total Debt (Recent Filing)$48.04M
Price to Earnings (P/E)-0.4
Aug 10, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.07
Shares Outstanding56,351,647
10 Day Avg. Volume139,501
30 Day Avg. Volume778,350
Standard Deviation0.22
Financial Highlights & Ratios
Price to Book (P/B)-6.81
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.94
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.64
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Molecular Templates Inc’s price range in the past 12 months?
Molecular Templates Inc lowest stock price was $0.31 and its highest was $1.23 in the past 12 months.
    What is Molecular Templates Inc’s market cap?
    Currently, no data Available
    When is Molecular Templates Inc’s upcoming earnings report date?
    Molecular Templates Inc’s upcoming earnings report date is Aug 10, 2023 which is in 63 days.
      How were Molecular Templates Inc’s earnings last quarter?
      Molecular Templates Inc released its earnings results on May 15, 2023. The company reported $0.19 earnings per share for the quarter, beating the consensus estimate of -$0.287 by $0.477.
        Is Molecular Templates Inc overvalued?
        According to Wall Street analysts Molecular Templates Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Molecular Templates Inc pay dividends?
          Molecular Templates Inc does not currently pay dividends.
          What is Molecular Templates Inc’s EPS estimate?
          Molecular Templates Inc’s EPS estimate is -$0.33.
            How many shares outstanding does Molecular Templates Inc have?
            Molecular Templates Inc has 56,351,646 shares outstanding.
              What happened to Molecular Templates Inc’s price movement after its last earnings report?
              Molecular Templates Inc reported an EPS of $0.19 in its last earnings report, beating expectations of -$0.287. Following the earnings report the stock price went up 9.524%.
                Which hedge fund is a major shareholder of Molecular Templates Inc?
                Among the largest hedge funds holding Molecular Templates Inc’s share is Woodline Partners LP. It holds Molecular Templates Inc’s shares valued at N/A.


                  Molecular Templates Stock Smart Score

                  This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Molecular Templates Inc

                  Molecular Templates, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. The company utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. Molecular Templates was founded on October 17, 2001 and is headquartered in Austin, TX.


                  Top 5 ETFs holding MTEM

                  Currently, no data available
                  Please return soon. This page is being updated.
                  Up to five ETFs with an Outperform Smart Score that hold MTEM. The ETFs are listed according to market value of MTEM within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Adaptimmune Therapeutics
                  Kura Oncology

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis